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Background : Acute aortic syndrome (AAS) is a potentially fatal disease involving the acute disruption of the 
aortic wall. Several conditions, such as intramural hematoma (IMH), aortic dissection (AD), penetrating 
atherosclerotic ulcer (PAU), as well as high mortality rates, are associated with this disease. Hypertension is an 
essential risk factor, and patients often present with pain. AAS may be challenging to be evaluated, as it has a 
pre-test probability and several diagnostic tests.
Objective : This literature review will discuss the proper diagnosis and management of Acute aortic 
Syndrome patients.
Discussion : Computed Tomography Angiography (CTA) is essential in managing AAS. The significance of prompt 
diagnosis and treatment of AAS is emphasized further by the current developments in imaging techniques and 
therapeutic interventions, ultimately leading to increased vigilance of this disease. Management of AAS included 
initial medical therapy and definitive therapy.
Conclusion : In A type AAS, surgical intervention is the definitive therapy, while type B is managed definitively by 





 One of the most perilous emergencies in cardiology is acute 
aortic syndrome (AAS), which is defined as acute disruption of the 
aortic wall.1,2 Several conditions, such as intramural hematoma (IMH), 
aortic dissection (AD), penetrating atherosclerotic ulcer (PAU), as well 
as high mortality rates, are associated with this disease.2 This condition 
affects 20 to 40 people/1000 000 population annually, with most of 
them are in the form of aortic dissection (80%), followed by IMH and 
PAU (15% and 5%, respectively).3 According to the data, within the 20 
years of 1990-2010, there was an increase in the overall global death 
rate due to aortic aneurysms and aortic dissection from 2.49 per 100 
000 to 2.78 per 100 000 residents with a higher tendency for elderly 
males.4 However, despite improvement in surgical techniques, early 
mortality rates of type A Aortic dissection remains constant during the 
last 30 years at 20% to 35%. 5,6
 There are several predisposing factors of aortic dissection, 
with hypertension being the most prevalent (72%). Approximately 31% 
of patients had a history of atherosclerosis, and correlation with 
Marfan’s syndrome and iatrogenic causes were found in several 
patients (5% and 4%, respectively).2 The risk factors for IMH and  
PAU was hypertension, hypercholesterolemia, and smoking.7 The 
significance of prompt diagnosis and treatment of AAS is emphasized 
further by the current developments in imaging techniques and 
therapeutic interventions, ultimately leading to increased vigilance of 
this disease.8,9 Corroboration of clinical suspicion, localization of tears, 
classification, and determination of urgency and the extent of dissec-
tion are the primary goals of diagnostic imaging studies upon clinical 
suspicion of AAS.8
2. Discussion
2.1 Pathophysiology of Acute Aortic Syndrome
 Histopathologic and genetic elements play essential roles in 
the diverse pathophysiology of acute aortic dissection.9 Acute aortic 
syndromes may develop during a buildup of blood within the tunica 
media of the aorta due to vasa vasorum rupture or whenever blood 
infiltrates the media through the lumen due to tear or ulcer (Figure 1). 
Dilation or rupture of the aorta may occur due to the inflammatory 
response in the media towards blood. This response will eventually end 
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In essence, every mechanism that compromised the media of the aorta 
may ultimately cause intramural hemorrhage and aortic dissection and 
rupture due to the formation of aneurysms and dilatation of the aorta 
caused by higher wall stress. In acute aortic dissection, medial wall 
degeneration or medial cystic necrosis is causing the tear in the intima 
layer of the aorta.1,9
 The blood flow within the aortic wall causes the dissection to 
propagate in an antegrade and retrograde manner. Whenever there is 
an involvement of aortic side branches, complications in the form of 
aortic valve insuciency, perfusion impairment, and tamponade arise 
[10]. Enhanced fluorodeoxyglucose (FDG) uptake on PET scan shows 
the degeneration of elastic tissue, necrosis, and apoptosis of smooth 
muscle cells.11 An increased risk of rupture in patients with concurrent 
inflammatory disorders such as Takayasu's disease, Behçet's syndrome, 
or polyarteritis nodosa, highlights the significance of this continued 
inflammation.12 There are multitudes of varying factors that promote 
AAS.
2.2 Classification of Acute Aortic Syndrome 
2.2.1 Aortic Dissection (AD)
 In essence, aortic dissection is the separation of aortic wall 
layers due to the disarrangement of media-induced by intramural 
hemorrhage, which leads to the formation of a true and a false lumen 
with or without communication. Accumulation of blood within the 
media in a dissection plane is instigated by the tear in the intimal layer. 
Blood then re-enters the aortic lumen via another tear in the intima, 
and aortic rupture may also occur due to the disruption of the adventi-
tia layer. The risk of medial rupture is increased due to the degenera-
tion of elastic tissue and necrosis and apoptosis of smooth muscle cells 
triggered further by inflammatory response to thrombus within the 
media.4 Type A and B AD may account for 62% and 38 % of cases, 
respectively.13
2.2.2 Intramural Haematoma (IMH)
 IMH is a condition where a hematoma develops in the media 
of the aortic wall in the absence of a false lumen and intimal tear. The 
finding of 5-mm circular or crescent-shaped thickening of the aortic 
wall in the absence of detectable blood flow is the basis for intramural 
hematoma diagnosis. Around 10%-30% of cases are attributable to 
Type A IMH (ascending aorta and aortic arch), while Type B (descend-
ing thoracic aorta) is responsible for 60%-70% of cases.4
2.1.3 Penetrating Atherosclerotic Ulcer (PAU)
 Penetration of ulcerative atherosclerotic plaque in the aorta 
into the medial layer is termed as PAU. A pseudoaneurysm, IMH, acute 
AD, or aortic rupture may occur due to the extension of the ulcerative 
process. It is expedited in ascending aorta (Type A). The presence of 
multiple variably sized extensive atherosclerosis in the thoracic aorta 
with variable depth within the wall might increase the likelihood of 
encountering PAU. The Middle and lower descending thoracic aorta are 
the most prevalent location of PAU (Type B). The aortic arch or abdomi-
nal aorta might also be the sites for PAU, albeit less commonly, while 
ascending aorta is a much rarer sight to be involved.4
2.3 Diagnosis
2.3.1 Clinical Presentation
 Irrespective of the underlying condition (e.g., contained 
aortic rupture, AD, PAU, or IMH), there is a similarity in the presenta-
tion in AAS patients. Acute aortic dissection patients most frequently 
present with a chief complaint of pain. Approximately 90% of over 
1000 cases showed a severe pain pattern and occurred abruptly in 84% 
of cases. The pain is often described as stabbing or sharp, which 
fluctuates, contrasting with the classical description of acute dissection 
pain ripping or tearing. The location of initial disruption might be 
inferred based on the pain location and respective symptoms. The 
involvement of ascending aorta might be indicated by pain that radiates 
to the neck, throat, or jaw; especially those which occur concurrently 
with pulse differentials, signs of tamponade, or aortic regurgitation 
murmur; on the contrary, dissection of the descending aorta must be 
suspected when the pain is located at the back or abdomen. The pain of 
aortic origin must not be mistaken for acute coronary syndromes.10,13 
Clinical findings alone might be insufficient to distinguish between 
classical dissection and IMH and PAU clearly. Patients often present 
with abrupt severe chest or back pain, especially in the elderly; howev-
er, this pain only seldomly manifests as signs of organ malperfusion and 
pulse deficit.7 Several major causes for delay in diagnosing AAS include 
heart failure, syncope, and abdominal pain.12  Pre-test probability might 
influence the outputs of diagnostic tests. A risk assessment tool was 
developed by the ACC/AHA. This tool scores patients’ pain features, 
clinical examination, and predisposing conditions on a scale of 0 (none) 
to 3.4
2.3.2 Laboratory testing
 Upon clinical suspicion of CAD in patients presenting with 
chest pain, laboratory tests are needed to determine differential diagno-
sis and complications. These tests include complete blood count, procal-
citonin, C -reactive protein, Troponin I or T, Creatine kinase, D-Dimer, 
Aspartate transaminase, Creatinine, lactate, blood gas, and glucose.4 
One of the most promising diagnostic biomarkers to achieve the gold 
standard as a form point-of-care test is D-dimer. Clinical suspicion of AD 
is raised whenever there is an increase of D-dimer (cut off value: 500 
ng/ml). There is also a piece of good evidence that states D-dimer's 
potential ability to rule out AD.14,15 
2.3.3 Electrocardiography
 Electrocardiography (ECG) is mandatory testing for all 
patients. It may distinguish between different origins of pain, such as 
those due to acute myocardial infarction in which anticoagulant might 
be used in the management, from those due to aortic dissection in 
which anticoagulant is contraindicated. However, it is essential to note 
that both conditions may occur concurrently and can only be elucidated 
by thorough clinical evaluation and testing. Around 31% of the patients 
had normal ECG, followed by nonspecific ST and T-wave changes, 
ischemic changes, and evidence of an acute MI in 42%, 15%, and 5%, 
respectively.1
2.3.4 Chest X-Ray 
 Widening of the aorta is one of the possible findings in 
conventional chest radiography in cases of aortic dissection. Aortic 
kinking, widening of the aortic contour, opacification of the aorticopul-
monary window, and displaced calcification are other examples of 
probable findings in this condition. Around 60%-90% of cases with 
suspected aortic dissection might display abnormalities in their chest 
radiography, while the remaining 10%-20% will have a normal chest 
x-ray. However, additional imaging studies need to be performed in 
almost all patients due to the limited sensitivity.1
2.4 Imaging Studies
2.4.1 Echocardiography
 The use of transthoracic echocardiography (TTE) to facilitate 
prompt diagnosis in an emergency setting as a part of a multidisci-
plinary approach has been widely acknowledged. 
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Important information which might be helpful in scenarios where 
prompt decision-making is required might be obtained by performing 
focused TTE on the aortic valve and aorta segments along with a 
glimpse of left heart function. Potentially life-threatening complications 
of AD can be rapidly detected by TTE, and such complications include 
wall motion abnormalities, pericardial effusion, aortic regurgitation, 
and cardiac tamponade; however, TTE has relatively low accuracy in 
detecting AD (Type A AAD has a sensitivity of 78–100%, while Type B 
only has 31–55%). Thus, AAD cannot be ruled out based on a negative 
TTE.15
 Transesophageal echocardiography (TEE) can visualize the 
aorta better than TTE, with higher image quality and spatial resolution 
to evaluate true lumen compression, secondary communications, and 
primary entry tear better. Combined with color flow patterns and flap 
movement, these parameters may have prognostic value. Intraproce-
dural monitoring can also be done by leaving the ultrasound probe in 
place.12
 Thickening of the aortic wall can also be assessed using TEE. 
Even though it cannot differentiate between acute versus chronic 
hematoma, it is also valuable for establishing other differential diagno-
ses that involve aortic wall thickenings like aortitis or severe atheroscle-
rosis. In any imaging modality, The thickness of greater than 5 mm in 
the presence of clinical symptoms suggesting AAS might point to a 
diagnosis of IMH. Echolucent or echo-free space inside the thickened 
aortic wall is a hallmark finding of IMH. There is a considerable amount 
of challenge in diagnosing IMH in its early state. Visualization of small 
communications and assessment of the intima is best performed using 
TEE with color Doppler. In TEE, PAU might appear a localized 
crater-like protrusion of the aortic lumen without intimal flap.7
2.4.2 Computed Tomography (CT)
 CT is the most commonly used modality due to its speed and 
high sensitivity in detecting AD (95%). The overall accuracy is 96%. 
Findings of highly attenuated hemorrhagic collection within the 
mediastinum, pericardium, and pleura, as well as active contrast extrav-
asation, are considered diagnostic.4,7 Usually, in an emergency depart-
ment setting, a CT scanner is located within a reachable distance to 
enable unstable patients to be rapidly examined radiographically. Rapid 
interpretation upon completion of the examination is a must, as it will 
enable rapid triage decisions. Nonspecific acute chest pain may be 
evaluated by multi-detector helical CT.9 
 The presence of two lumens separated by the intimal flap is 
an essential finding on contrast-enhanced images. Multiplanar 
reconstruction images are essential in helping to corroborate the 
diagnosis and determine the extent of involvement (mainly when aortic 
branch vessels are involved), even though AD can be diagnosed using 
transverse CT images. Multidetector CT plays a pivotal role in measur-
ing the length, true lumen (TL) and false lumen (FL) of the aorta, the 
extent of dissection, the distance from the intimal tear to the vital 
vascular branches, and involvement of vital vasculature in a precise and 
specific manner. Slower flow and a large diameter lumen that may 
contain thrombi are characteristics of FL. ‘Cobweb sign’ is a hallmark 
finding for FL. It is characterized by low attenuation of slender linear 
areas, which depicts the incompletely dissected media. FL in type A AD 
then extends distally, in a spiral fashion. In many instances, TL is the 
lumen that extends more caudally. It is essential to differentiate 
between FL and TL to decide when to consider endovascular therapy.4 
 The mainstay protocol for CT examination for chest pain is 
the triple rule-out protocol, the purpose of this protocol is to dierenti-
ate between acute aortic dissection, pulmonary embolism, and acute 
coronary syndrome. Future triple rule-out protocols may potentially 
diminish the number of diagnostic tests, time for triage, radiation 
exposure to the patient, and emergency department costs, even though 
limitations do exist. Motion artifacts that may be similar to findings of 
type A AD may pose a diagnostic challenge in the evaluation of AD, 
particularly in ascending aorta; however, ECG gating might solve this 
issue.9 The crescentic or circular highly-attenuated area on CT, which 
did not enhance after contrast medium injection, is diagnostic for IMH 
7 Contrast-filled pouch-like protrusion in the thickened aortic wall is the 
typical finding for PAU in an atherosclerotic process. Besides 
ulceration, extensive atherosclerosis is also commonly found.7
2.4.3 Magnetic Resonance Imaging (MRI)
 A comprehensive evaluation of aortic dissection might be 
obtained from an MRI examination, as it can merge anatomical and 
functional aspects in imaging. Pre- and post-treatment evaluation of the 
aorta is frequently done by contrast-enhanced MR angiography 
(CE-MRA). CE-MRA has a high tissue contrast and a short scan time. 
Iodinated agents used with CTA are less preferred than gadolini-
um-based contrast due to their higher nephrotoxicity. Rarely, nephro-
genic systemic fibrosis as an adverse reaction may occur. Assessment of 
flow dynamics might be conducted using time-resolved MR angiogra-
phy (MRA), which yields additional information and images. Sequen-
tial visualization of the true and false lumen is done by rapid acquisi-
tion of MRA sequences synchronized with the ECG. MRI is typically 
slower than CT imaging, despite improved MR scan times due to image 
acceleration techniques. MRI is expected to be extensively used with 
better availability.7 CMR can easily detect crescentic aortic wall 
thickening without the intimal flap; methemoglobin formation within 
the hematoma causes the signal of the thickened aorta to intensify, 
which resulted in increased signal intensity on T1-weighted images in 
subacute IMH. However, it is important to remember that to correctly 
identify the extent of IMH and periaortic bleeding, the broad field of 
vision of CT and CMR must be taken into account. Several frequent 
findings of IMH include the presence of fluid extravasation, mediastinal 
hemorrhage, as well as pericardial and pleural effusion.7 Irregular 
contrast-filled ulcerative plaque outpouching beyond the aortic intima 




 Historically, the gold standard for diagnosing AAS is 
retrograde aortography, with a sensitivity of up to 90% and specificity 
of > 95%. The angiographic diagnosis of AD is based upon ‘direct’ 
angiographic signs, such as the visualization of the intimal flap (a 
negative, frequently mobile, linear image) or the recognition of two 
separate lumens. The invasive, time-consuming, and high-cost natures 
of this modality are the reasons why this modality is no longer used to 
diagnose AAS.4,15
2.5.2 Intravascular ultrasound
 Intravascular ultrasound is a reliable and safe tool to guide 
stent-graft positioning and provide real-time imaging of aortic patholo-
gy. However, the shortcoming of Doppler capabilities and the likelihood 
of off-center measurements continue to be an important limitation. 
Another possible approach to guide fenestration procedures is to 
identify communications between the true lumen and false lumen.15
2.5.3 Positron Emission Tomography
Currently, the role of 18F-fluorodeoxyglucose (18F-FDG) positron 
emission tomography (PET) has grown in importance during
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the evaluation of pathological processes of the aortic wall (i.e., inflam-
matory and/or infectious processes). The limited spatial resolution of 
PET has drastically improved due to PET/CT angiography or magnetic 
resonance angiography image acquisition, resulting in excellent 
anatomical visualization of mural or luminal abnormalities, enabling 
accurate localization of lesions. Increased levels of inflammatory 
serological markers (CRP and D-dimer), enhanced 18F-FDG uptake in 
the wall of an acute dissected aorta as shown by PET signal, and/or 
thrombus renewal/lysis (D-dimer, plasmin–alpha 2–antiplasmin 
complexes, thrombin–antithrombin III complexes, and P-selectin), may 
possess a potential added value of risk prediction for follow-up.15
2.6 Management of Acute Aortic Syndrome
2.6.1 Initial Medical Therapy
 The goal of initial medical therapy in all AAS patients is to 
reduce wall stress (irrespective of the definitive treatment) to reduce 
the risk of developing end-organ damage and rupture and restrain the 
extension of the dissection. It is imperative to provide adequate pain 
relief (intravenous opiate analgesia) and control of systolic blood 
pressure ranges from 100 to 120 mmHg and heart rate less than 60 
bpm. Intravenous beta-blockers (labetalol, propranolol, esmolol, or 
metoprolol) are the first-line drugs for these purposes. A feasible 
alternative for patients who cannot tolerate beta-blockers is non-dihy-
dropyridine calcium channel antagonists (i.e., verapamil and 
diltiazem). Concurrent administration of vasodilators (intravenous 
sodium nitroprusside) and beta-blockers might be required to rapidly 
attain the optimal level of blood pressure.15 Other treatment includes 
restriction of strenuous physical activity, administration of long term 
ACE/ARB, pain control using opiate, achieving an LDL cholesterol 
target of less than 70 mg/dL by administration of statin (IIaA), and 
cessation of smoking (IB).12
2.6.2 Definitive Therapy
 Asian, European, and American practice guidelines contain 
recommendations for the definitive treatment of AAS, which are 
slightly different among one another in terms of the level of evidence 
underlying these recommendations (Figure 8).16,17 AAS of the ascending 
aorta is considered surgical emergencies; one may consider a hybrid 
approach in selected cases, which is to combine endovascular and open 
approaches. On the contrary, medical treatment should be instituted in 
cases of acute aortic pathology limited to the descending aorta, except 
in the presence of complications (i.e., progressive dissection, organ or 
limb malperfusion, uncontrolled hypertension, intractable pain, or 
extra aortic blood collection (impending rupture)). However, most 
recommendations are based on Level C evidence because large RCTs 
regarding AAS are still lacking.10,18
 The benefit of thoracic endovascular aortic repair (TEVAR) 
in managing patients with type B AD is still controversial. In order to be 
able to identify optimal indications for TEVAR, large-scale RCTs with 
long-term follow-up are still required. Investigation of Stent Grafts in 
Aortic Dissection trial found an improvement in 5-year survival, 
positive remodeling, and delayed disease progression upon the use of 
TEVAR along with optimal medical treatment; and yet, the results also 
revealed that there was no difference in total mortality.15,19,20
3. Conclusion
 AAS is a potentially fatal disease besides ACS, which 
mandates timely management. Clinical features of AAS and its 
subsequent consequences are crucial to be comprehended. Imaging is 
an integral part of AAS management, with CTA being the most promi-
nent modality. CTA has the advantage of being able to evaluate predic-
tors of progression, ascertain complications and end-organ ischemia. 
Moreover, it can also visualize the anatomy and the extent of lesions 
well and can be performed swiftly. Recommendations for the manage-
ment of AAS included initial medical therapy and definitive therapy. In 
A type AAS, surgical intervention is the definitive therapy, while type B 
is managed definitively by endovascular or medical treatment.
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